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ABSTRACT
Centrioles function as core components of centrosomes and as
basal bodies for the formation of cilia and flagella. Thus, effective
control of centriole numbers is essential for embryogenesis, tissue
homeostasis and genome stability. In mammalian cells, the centriole
duplication cycle is governed by Polo-like kinase 4 (Plk4). Here, we
identify the E3 ubiquitin ligase Mind bomb (Mib1) as a new
interaction partner of Plk4. We show that Mib1 localizes to
centriolar satellites but redistributes to centrioles in response to
conditions that induce centriole amplification. The E3 ligase activity
of Mib1 triggers ubiquitylation of Plk4 on multiple sites, causing the
formation of Lys11-, Lys29- and Lys48-ubiquitin linkages. These
modifications control the abundance of Plk4 and its ability to interact
with centrosomal proteins, thus counteracting centriole amplification
induced by excess Plk4. Collectively, these results identify the
interaction between Mib1 and Plk4 as a new and important element
in the control of centriole homeostasis.
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INTRODUCTION
Centrioles play important functions in the organization of
microtubule arrays. A pair of centrioles, surrounded by
pericentriolar material (PCM), constitutes the centrosome, the
main microtubule-organizing center of animal cells (Bornens,
2012; Go¨nczy, 2012; Nigg and Stearns, 2011). In addition,
centrioles function as basal bodies, or templates, for the
axonemes of cilia and flagella (Ishikawa and Marshall, 2011;
Santos and Reiter, 2008). In proliferating cells, centrioles duplicate
exactly once per cell cycle through the formation of one new
centriole close to the proximal end of each pre-existing centriole
(Azimzadeh and Bornens, 2007; Firat-Karalar and Stearns, 2014;
Nigg and Stearns, 2011). Proper control of centriole biogenesis is
crucial for embryogenesis, tissue homeostasis and genome stability
(Bettencourt-Dias et al., 2011; Godinho and Pellman, 2014;
Chavali et al., 2014; Nigg et al., 2014). Dysfunction of the
centriole-ciliary apparatus and/or centrosomes is implicated in the
etiology of ciliopathies, brain diseases, dwarfism and cancer
(Bettencourt-Dias et al., 2011; Godinho and Pellman, 2014;
Hildebrandt et al., 2011; Nigg and Raff, 2009; Thornton and
Woods, 2009).
Centriole biogenesis in human cells and Drosophila melanogaster
is governed by Polo-like kinase 4 (Plk4, also known as Sak), a
distant member of the Polo kinase family (Bettencourt-Dias et al.,
2005; Habedanck et al., 2005); in Caenorhabditis elegans an
analogous function is attributed to the kinase ZYG-1 (O’Connell
et al., 2001). Tight control of Plk4 levels is crucial, as its depletion
leads to a gradual loss of centrioles and its overexpression to
centriole amplification (Bettencourt-Dias et al., 2005; Habedanck
et al., 2005; Kleylein-Sohn et al., 2007; Rodrigues-Martins et al.,
2007). One important mechanism for controlling Plk4 abundance is
based on the ability of Plk4 to dimerize and trans-autophosphorylate,
which results in the generation of a phosphodegron for recognition
by Skp, Cullin, F-box containing complex coanatining b-TrCP
(SCFb-TrCP), an E3 ligase, and subsequent degradation of Plk4 by
the proteasome (Cunha-Ferreira et al., 2013; Cunha-Ferreira et al.,
2009; Guderian et al., 2010; Holland et al., 2012; Holland et al.,
2010; Klebba et al., 2013; Sillibourne et al., 2010). Other regulatory
mechanisms are likely to exist, and a full understanding of Plk4
regulation is important, particularly in view of the frequent
deregulation of this kinase in human cancers (Chng et al., 2008;
Macmillan et al., 2001; Mason et al., 2014; van de Vijver et al.,
2002) and the impact of Plk4 mutations on brain development and
body growth (Martin et al., 2014).
Here, we report on a new interaction between Plk4 and the E3
ubiquitin ligase Mind bomb 1 (Mib1). This comes as a surprise,
as Mib1 has previously been studied mainly in the context of
Notch and nuclear factor (NF)-kB signaling (Barsi et al., 2005;
Daskalaki et al., 2011; Itoh et al., 2003; Li et al., 2011; Liu et al.,
2012). However, recent reports have described associations of
Mib1 with centriolar satellites, small multiprotein clusters in the
vicinity of centrosomes (Akimov et al., 2011; Jakobsen et al.,
2011; Tollenaere et al., 2014; Villumsen et al., 2013). Here, we
confirm that Mib1 localizes to centriolar satellites but
additionally show that Mib1 relocates to centrioles in response
to stimulation of centriole biogenesis. Moreover, we demonstrate
that Mib1 interacts with Plk4 and promotes its ubiquitylation.
This in turn affects Plk4 abundance and localization, with
important consequences for centriole homeostasis.
RESULTS AND DISCUSSION
Recent proteomics and yeast two-hybrid studies have hinted at a
centrosome-associated function for the E3 ubiquitin ligase Mib1
(Akimov et al., 2011; Jakobsen et al., 2011; Tseng et al., 2014). In
line with these results, we found that Mib1 colocalizes with PCM-
1 (Fig. 1A, top left), a marker for centriolar satellites
(Dammermann and Merdes, 2002). Furthermore, we could
detect Mib1 in the vicinity of centrosomes in interphase but not
mitotic cells (supplementary material Fig. S1), in agreement with
Biozentrum, University of Basel, Klingelbergstrasse 50/70, 4056, Basel,
Switzerland.
*Present address: Department of Histology and Embryology, Faculty of Medicine,
Masaryk University, Kamenice 3/A1, 62500 Brno, Czech Republic.
`Author for correspondence (erich.nigg@unibas.ch)
Received 24 November 2014; Accepted 18 March 2015
 2015. Published by The Company of Biologists Ltd | Journal of Cell Science (2015) 128, 1674–1682 doi:10.1242/jcs.166496
1674
Fig. 1. Interaction of Mib1 with Plk4. U2OS (A) or U2OS:Myc-Plk4 cells (B) were fixed and stained with the indicated antibodies. Scale bar: 0.5 mm. (A) Cells
were synchronized in S phase (aphidicolin, 24 h) and treated for 4 h with vehicle or taxol (5 mM); siRNA-treated cells were synchronized in S phase and
fixed 48 h after transfection, and stained for PCM-1 (green), Mib1 (red) and the centriole marker Cep135 (blue). (B) Control (2Tet) or tetracycline (+Tet)-treated
(12 h) U2OS:Myc-Plk4 cells were stained with the indicated antibodies. (C,D) Western blot analyses of immunoprecipitated (IP) complexes from HEK293T cells
transfected with the indicated construct. Asterisk denotes detection of a weak band corresponding to the complex between Plk4 and full length Mib1. TCL,
total cell lysate. (E) Schematic representation of Mib1 domains interacting with Plk4. Symbols (+), +, ++, or 2 refer to the efficacy of co-immunoprecipitation.
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reports of PCM-1 localization (Balczon et al., 1994). Centriolar
satellite localization of both Mib1 and PCM-1 was abolished by
taxol treatment, suggesting a dependency on intact microtubules
(Fig. 1A, top right). Moreover, siRNA-mediated depletion of
PCM-1 resulted in a redistribution of Mib1 to centrioles (Fig. 1A,
bottom), reminiscent of the behavior of the centriolar satellite
proteins Cep72 and Cep290 (Lopes et al., 2011; Stowe et al., 2012).
Furthermore, overexpression of Myc–Plk4 in either U2OS or RPE-
1 cells also triggered re-localization of Mib1, but not PCM-1, to
centrioles (Fig. 1B; supplementary material Fig. S2A,B). The same
phenotype was seen when Plk4 levels were raised through
depletion of b-TrCP (supplementary material Fig. S2C) or when
centriole amplification was induced through transient transfection
of Plk4 or the centriole duplication factors STIL or Sas6 (also
known as SASS6) (supplementary material Fig. S2D). Moreover,
MCF-7 breast cancer cells, which are prone to centriole over-
duplication upon loss of p53 (D’Assoro et al., 2004), showed
increased levels of Plk4 and, concomitantly, more pronounced
Mib1 signals at centrioles, when compared to RPE-1 cells
(supplementary material Fig. S2E–G). Thus, we conclude that
Mib1 localizes to centrioles in response to Plk4 elevation and
centriole over-duplication, raising the prospect of a functional link
between Mib1 activity and the regulation of centriole duplication.
Next, we examined a possible interaction between Mib1 and
Plk4. Only trace amounts of wild-type Flag–Mib1 could be co-
immunoprecipitated with Myc–Plk4 but, remarkably, strong
binding was seen between Plk4 and a Flag–Mib1DRING
mutant (Fig. 1C,D), which is catalytically inactive (Berndt
et al., 2011; Itoh et al., 2003). Myc–Cep135, analyzed as a
control, was unable to bind either wild-type or mutant Mib1
(Fig. 1C). A Mib1 mutant carrying a point mutation (C997S) that
disrupts one of the three RING fingers (Berndt et al., 2011) also
showed poor binding to Plk4 (Fig. 1C,D), in line with
observations that this mutant is at least partially active when
overexpressed in cells (Berndt et al., 2011; and data not shown).
Using Mib1 deletion mutants (Fig. 1E), binding of Myc–Plk4
could be mapped to the N-terminal but not C-terminal part of
Mib1 (Fig. 1C,D). Complex formation could also be detected
between Myc–Plk4 and endogenous Mib1 (supplementary
material Fig. S2H) and between Plk4 and Mib1 proteins
produced by in vitro translation (supplementary material Fig.
S2I), supporting a direct interaction.
The striking difference in the ability of catalytically active and
inactive Mib1 to co-immunoprecipitate with Plk4 raised the
possibility that Mib1 might act as an ubiquitin ligase for Plk4.
Indeed, transient overexpression of wild-type Flag–Mib1 resulted
in the appearance of higher migrating forms of Myc–Plk4
(Fig. 2A), but not Myc–Cep135 (Fig. 2B). Importantly, this Plk4
modification was induced only by Mib1 full length protein, but
not by Mib1 deletion mutants (Fig. 2A), even though the latter
showed much stronger binding to Plk4 (Fig. 1C,D). To determine
the nature of this Mib1-dependent modifications, we co-
expressed Myc–Plk4 with His-tagged ubiquitin and either wild-
type Flag–Mib1 or Mib1DRING, respectively, and then isolated
poly-ubiquitylated protein species. Remarkably, Flag–Mib1 wild-
type, but not catalytically inactive Mib1DRING, efficiently
promoted poly-ubiquitylation of Myc–Plk4 (Fig. 2C), but not
Myc–Cep135 (supplementary material Fig. S3A).
Given that steady-state levels of Plk4 are regulated by the E3
ligase SCFb-TrCP (Cunha-Ferreira et al., 2009; Guderian et al.,
2010; Rogers et al., 2009), we tested the possible involvement of
this ligase in Mib1-mediated ubiquitylation of Plk4. As expected,
depletion of b-TrCP caused an increase in active b-catenin (ABC;
Fig. 2D), a direct target of SCFb-TrCP (Hart et al., 1999; van Noort
et al., 2002), as well as increased levels of Plk4 at centrosomes
(supplementary material Fig. S3B). In striking contrast, b-TrCP
depletion did not affect Mib1-induced ubiquitylation of Myc–
Plk4 (Fig. 2D), arguing that SCFb-TrCP does not mediate Mib1
action on Plk4. We have not been able to obtain active full-length
Mib1 to demonstrate in vitro ubiquitylation of purified Plk4 and
thus cannot formally exclude an indirect mechanism. However,
the most parsimonious interpretation of our results is that Mib1
acts directly on Plk4.
Next, we used mass spectrometry to explore the nature of the
Mib1-induced ubiquitylation of Plk4. We identified a total of 15
ubiquitylated lysine residues within Plk4, many of which
clustered within the kinase domain, the linker region, and polo
box domains (Fig. 2E). When different moieties of Plk4 were
examined for their response to Mib1, most fragments showed a
mobility shift after 18 h of co-expression and downregulation
after 36 h of co-expression (supplementary material Fig. S3C). In
contrast, although mass spectrometry had revealed ubiquitylated
lysine residues within the PB1 or PB2 region of Plk4,
ubiquitylation of a corresponding fragment (residues 608–970)
did not lead to either a mobility upshift or downregulation
(supplementary material Fig. S3C). Taken together, these
experiments indicate that Mib1 modifies Plk4 on multiple sites,
likely involving more than one type of ubiquitylation. Depending
on the types of linkages, ubiquitin modifications might either
trigger protein degradation or serve to regulate protein
localization, activity or protein–protein interactions (Al-Hakim
et al., 2008; Ciechanover, 1998; Chen and Sun, 2009; Komander,
2009; Pickart and Eddins, 2004; Xu et al., 2009). To obtain
information about the types of Mib1-mediated ubiquitin chains
formed on Plk4 we performed ubiquitylation assays using His–
ubiquitin mutants that are able to contribute to only one particular
type of linkage. Mib1 mediated extensive ubiquitylation of Plk4
in presence of wild-type ubiquitin or mutants conferring K11-,
K29- and K48-based linkages, but K63-based ubiquitylation was
much less efficient (Fig. 2F). These results suggest that Mib1 is
able to induce formation of ubiquitin chains on Plk4 that are
typically associated with fast proteasomal degradation (K11 and
K48 linkages). In addition, Mib1 clearly induces formation on
Plk4 of at least one additional type of ubiquitin chain that is
commonly associated with regulatory events (K29 linkages).
Our identification of K11- and K48-based ubiquitin linkages
suggested that Mib1 might control Plk4 abundance. To examine
this possibility, we transfected Myc–Plk4-inducible U2OS
(denoted USOS U2OS:Myc–Plk4) cells with control or Mib1
small interfering RNA (siRNA) oligonucleotides, induced Myc–
Plk4 expression by tetracycline and 2 h later added cycloheximide
to inhibit protein translation (Fig. 3A). As shown by western
blotting (Fig. 3B) and quantified in Fig. 3C, Mib1 depletion led to
a significant increase in the levels of exogenous Myc–Plk4.
Overexpression of Plk4 in U2OS:Myc–Plk4 cells has been
previously shown to trigger centriole over-duplication
(Habedanck et al., 2005; Kleylein-Sohn et al., 2007) as reflected
in the formation of multiple procentrioles around each pre-existing
centriole (Fig. 3D). Interestingly, we found that centriole over-
duplication was enhanced upon Mib1 depletion from tetracycline-
treated U2OS:Myc–Plk4 cells, particularly when these were
synchronized in S phase by aphidicolin, indicating that Mib1
counteracts excess Plk4 activity (Fig. 3E). In contrast, depletion of
Mib1 from parental U2OS cells caused neither a significant
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Fig. 2. Mib1 ubiquitylates Plk4. (A,B) HEK293Tcells were transfected with Myc–Plk4 (or Myc–Cep135 for control in B) and the indicated Flag–Mib1 constructs
before protein extracts were probed by western blotting. The bands marked with an asterisk (*) most likely represent cleavage fragments of Flag–Mib1.
(C) HEK293T cells were transfected with the indicated plasmids before His-pulldowns were analyzed by western blotting. (D) HEK293T cells were transfected
with the indicated plasmids and subjected to b-TrCP siRNA (or control siRNA) before extracts were probed with antibodies against Myc, Flag, ABC (active
b-catenin) and a-tubulin. Numbers below the top panel indicate the signal ratio of modified (arrowhead) to unmodified (arrow) Myc–Plk4, presented as
mean6s.d. (n52). (E) Schematic representation of ubiquitylated lysine residues (K) within Plk4, as revealed by mass spectrometry (PB, polo box domain).
(F) HEK293Tcells transfected with the indicated plasmids before His-pulldowns were analyzed by western blotting. His–ubiquitin was used in wild-type form (wt)
or in mutant form able to contribute only to specific types of ubiquitin chains, notably, K29-only, K48-only or K63-only. TCL, total cell lysate.
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increase in centrosomal levels of Plk4 (Fig. 3F) nor centriole
amplification (Fig. 3G), although both these phenotypes could
readily be observed upon depletion of b-TrCP (Fig. 3F,G). These
results suggest that the ubiquitin ligase activity of Mib1 becomes
important primarily in response to excess Plk4, whereas normal
cell cycle regulation is exerted primarily by SCFb-TrCP.
We also examined the impact of Mib1 overexpression on Plk4
levels. We found that overexpression of Flag–Mib1, but not Flag–
Mib1DRING, caused a marked decrease of Myc–Plk4 levels at
centrioles (Fig. 4A,B), and similar effects were seen also upon
endogenous Plk4 (Fig. 4C,D). Similarly, Mib1 caused
downregulation when Plk4 levels were elevated by b-TrCP
depletion (supplementary material Fig. S4A,B), and expression of
Flag–Mib1 in the U2OS:Myc-Plk4 cell line greatly impaired the
ability of exogenous Myc–Plk4 to trigger centriole over-
duplication (Fig. 4E,F). Taken together, these results
demonstrate that Mib1 is able to reduce centriolar levels of
Plk4 and thereby counteract Plk4-induced centriole over-
duplication. Flag–Mib1 overexpression also caused a reduction
in centriolar levels of Sas6 (supplementary material Fig. S4C,D),
in line with recent studies showing that Plk4 is required for the
recruitment of Sas6 to centrioles (Dzhindzhev et al., 2014; Kratz
et al., 2015; Ohta et al., 2014). Interestingly, Mib1 also caused a
mobility upshift in Sas6, but not in STIL (supplementary material
Fig. S4E). The significance of this upshift will require further
study. One possibility is that Sas6 is an additional target of Mib1,
in which case Sas6 ubiquitylation might also contribute to the
effects of Mib1 on centriole duplication.
In addition to K48-linked ubiquitin chains, we observed
ubiquitin chains on Plk4 that are not generally related to fast
proteasomal protein degradation (Al-Hakim et al., 2008;
Komander, 2009; Xu et al., 2009). This most likely explains
why Mib1-induced ubiquitylated species of Plk4 could readily be
detected without use of proteasome inhibitors (Fig. 3A–C).
Considering that we were able to map ubiquitylated lysine
residues to regions that are essential for Plk4 functionality,
notably the kinase domain, the linker region and the polo box
domains (Fig. 2E), we asked whether ubiquitylation might affect
the interaction of Plk4 with its binding partners Cep192 and
Cep152 (Cizmecioglu et al., 2010; Dzhindzhev et al., 2010; Hatch
et al., 2010; Kim et al., 2013; Sonnen et al., 2013). We found that
affinity purified LAP–Plk4, ubiquitylated in a Mib1-dependent
manner, indeed showed reduced in vitro binding to both the GST-
tagged N-terminal of Cep192 and Cep152 (Fig. 4G–I). Taken
together, these results suggest that ubiquitylation by Mib1
negatively affects the ability of Plk4 to bind its centriole-
recruitment factors Cep152 and Cep192 (Kim et al., 2013;
Sonnen et al., 2013).
In conclusion, we show that Mib1 is important for regulating
Plk4 levels, particularly under conditions of aberrant Plk4
expression. Such conditions are known to occur in breast
cancer as well as other tumor types (Chng et al., 2008;
Macmillan et al., 2001; Mason et al., 2014; van de Vijver
et al., 2002). Specifically, we propose that SCFb-TrCP is the major
E3 ligase controlling steady-state Plk4 levels under physiological
conditions (Cunha-Ferreira et al., 2013; Cunha-Ferreira et al.,
Fig. 3. Mib1 counteracts excessive Plk4 levels. (A) Schematic design of
experiments with U2OS:Myc-Plk4 cells, as analyzed in B–E. Tet, tetracycline.
(B,C) Western blot analyses of protein extracts prepared from U2OS:Myc–
Plk4 cells treated with control or Mib1-specific siRNA. Relative Myc–Plk4
levels (normalized to tubulin, n53, two tailed t-test, **P50.0045) are
quantified in C. (D) Non-induced (2Tet) and induced (+Tet) U2OS:Myc–Plk4
cells were fixed and stained for CP110 (green), Myc–Plk4 (red), and the
centriole maker Cep135 (blue). Scale bar: 0.5 mm. (E) Quantification of Myc–
Plk4-induced centriole over-duplication (more than four CP110-positive
centrioles per cell) in asynchronously growing or S-phase arrested
(aphidicolin-treated) U2OS cells subjected to control or Mib1-specific siRNA
(mean6s.e.m., n54, one way-ANOVA). *P,0.05. (F) U2OS cells were
treated with the indicated siRNA oligonucleotides and stained after 48 h for
Plk4 (green) and Cep135 (red). Scale bar: 0.5 mm. (G) Quantification
(mean6s.e.m., n53, one way-ANOVA) of the effects of the indicated siRNA
treatments on centriole over-duplication (counted as in E). **P,0.01.
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Fig. 4. Mib1 negatively regulates centriole biogenesis and Plk4 interactions. (A,B) U2OS:Myc–Plk4 cells were transfected with the indicated plasmids,
treated for 2 h with tetracycline and then stained for Myc–Plk4 (green), Flag–Mib1 (red) and the centriole marker Cep135 (blue). A quantification (mean6s.e.m.,
n53, one way-ANOVA) is shown in B. (C) U2OS cells were transfected with the indicated plasmids and stained for endogenous Plk4 (green), Flag-Mib1 (red)
and Cep135 (blue). Quantification (mean6s.e.m., n52, one way-ANOVA) is shown in D. (E) Transfected U2OS:Myc–Plk4 cells were treated for 6 h with
tetracycline and stained for CP110 (green), Flag–Mib1 (red) and Cep135 (blue). Quantification (mean6s.e.m., n53, two way-ANOVA) is shown in F. (G,I)
Western blot analyses of the effect of Mib1-mediated ubiquitylation on binding of affinity-purified LAP–Plk4 to the GST-tagged Cep192 N-terminus (G) or GST-
tagged Cep152 N-terminus (I). Quantification of these results is shown in H (mean6s.e.m., n54, two tailed t-test, *P50.0315) and J (mean6s.e.m., n53, two
tailed t-test, *P50.0148), respectively. (K) Proposed model, as described in text. Scale bars: 0.5 mm.
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2009; Holland et al., 2012; Klebba et al., 2013) and that Mib1
might become important primarily in response to excess Plk4
(this study). As illustrated in Fig. 4K, our data indicate that Mib1-
induced ubiquitylation results in at least two functional consequences
for Plk4 and hence centriole numbers. First, Mib1 contributes to
control turnover of Plk4 through ubiquitin-dependent proteolytic
degradation. Second, Mib1-dependent ubiquitylation of Plk4 also
impairs the ability of Plk4 to interact with Cep152 and Cep192,
hence reducing its association with centrioles. Combined, these
Mib1-induced effects on Plk4 abundance and localization
contribute to control centriole numbers. In future it will be
interesting to explore the role of Mib1 in the control of Plk4 under
pathophysiological conditions, notably in human tumors with high
levels of centriole amplification. As one example, we have shown
here that Mib1 levels are enhanced at the centrioles of breast cancer
cells, MCF-7, which express higher levels of Plk4 than RPE-1
cells, and our model would indicate that this reflects a response to
deregulation of Plk4. However, it is also attractive to speculate that
tumors might exist in which a loss of Mib1 (or Mib2) activity
causes Plk4 overexpression and concomitant centriole duplication.
MATERIALS AND METHODS
Cell culture, transfections and drug treatments
U2OS, U2OS:Myc-Plk4 (Kleylein-Sohn et al., 2007), MCF-7 and
HEK293T cells were propagated in Dulbecco’s modified Eagle’s
medium (DMEM), and RPE-1 cells were grown in DMEM with F12.
Media were supplemented with 10% fetal bovine serum (FBS) and
penicillin-streptomycin (all from Life Technologies, Carlsbad, CA; FBS
for U2OS:Myc-Plk4 from PAA). Transfection was performed with
TransIT-LT1 (Mirus Bio, Madison, WI). siRNA experiments were
performed using Oligofectamine (U2OS cell) or Lipofectamine
RNAiMAX (HEK293T cells), both from Life Technologies. Control
(GL2) and Mib1 (targeting sequence, TTCTCATCCACAATCCA-
TGGT), PCM-1 (targeting sequence, AATCAGCTTCGTGATTCT-
CAG), or b-TrCP1 and b-TrCP2 (targeting sequence, GTGGAATTTGT-
GGAACATC) specific oligonucleotides were used at concentrations of
50–100 nM for 36–48 h. In some experiments, cells were transfected
with plasmids 32–36 h after siRNA transfection, as described above.
Expression of Myc-Plk4 in the U2OS:Myc-Plk4 cell line was induced by
tetracycline (1 mg/ml) for 2–12 h. Where indicated, cells were treated
with cycloheximide (50 mg/ml) or aphidicolin (1.6 mg/ml; 24 h).
Plasmids and cloning
Insert-containing entry vectors for use in the GATEWAY system (Life
Technologies) were generated by PCR, using Pfu Ultra II Fusion DNA
polymerase (Agilent, Santa Clara, CA). Inserts were verified by
sequencing and subsequently cloned into pDEST-Myc, pDEST-Flag,
pDEST-GST (Invitrogen), or pg-LAP1 (Addgene plasmid 19702)
GATEWAY destination vectors. All human cDNAs used here have
been described previously: Mib1 (Berndt et al., 2011), Plk4 (Habedanck
et al., 2005), Cep152 and Cep192 (Sonnen et al., 2013), Cep135
(Kleylein-Sohn et al., 2007), Ubiquitin wt and chain-specific mutants
(Chastagner et al., 2006).
Immunofluorescence microscopy
Methanol fixation of cells, blocking, incubation with primary and
secondary antibodies, and washing were performed as described (Sonnen
et al., 2012). The following antibodies were used: rabbit anti-PCM-1 was
raised by Charles River Laboratories against His-PCM-1 (amino acids
1022–1202), rabbit anti-Mib1 (M5948; Sigma-Aldrich, St.Louis, MI),
rabbit anti-Cep135, rabbit-CP110, rabbit anti-Plk4 (all described in
Kleylein-Sohn et al., 2007), mouse anti-Plk4 (Guderian et al., 2010),
mouse anti-Myc (clone 9E10), mouse anti-Flag (clone M2; Sigma-
Aldrich), Alexa-Fluor-488-conjugated donkey anti-mouse, Alexa-Fluor-
488-conjugated donkey anti-rabbit, Alexa-Fluor-488-conjugated donkey
anti-mouse, and Alexa-Fluor-488-conjugated donkey anti-rabbit (all from
Life Technologies). Direct labeling of primary antibodies was performed
using an Alexa-antibody labeling kit (Life Technologies). Imaging was
performed in Glycergel mounting medium (Agilent) at room temperature,
using a DeltaVision Core system (Applied Precision, Issaquah, WA) with
a 606/1.2 or 1006/1.4 Apo plan oil immersion objective, Photometrics
CoolSNAP CCD camera and solid state illumination. Image stacks were
taken with a z distance of 0.2 mm, deconvolved (conservative ratio, three
to five cycles), and projected as maximal intensity images by using
SoftWoRX (Applied Precision). For cell counts, 50–100 cells per
condition and experiment were analyzed. Densitometry analysis was
performed in 16-bit TIFF images with ImageJ within selected regions of
interest (ROIs); 15–20 cells per experiment and condition were analyzed.
Data are presented as relative staining intensity (staining intensity of a
protein of interest normalized to the intensity of centriolar marker
Cep135). Relative Mib1 levels at the centrosome (supplementary
material Fig. S2G) were measured as total intensities in ROIs using
Cell Profiler. The area of Cep135 signal, enlarged by 2ppx, was used to
create a mask to measure centriole-associated Mib1 staining. Contrast
and/or brightness adjustment and cropping of final images were done
using Photoshop CS5 (Adobe Systems, San Jose, CA).
Cell lysis, pulldown and western blotting
At 18 h post-transfection, cells were washed in PBS and lysed [62.5 mM
Tris-HCl, pH 6.8, 1% SDS, 10% glycerol (all from Sigma-Aldrich)].
Samples were processed as described previously (Bryja et al., 2005) and
analyzed by western blotting. The following antibodies were used, in
addition to those listed above: rabbit anti-Myc (sc-789; Santa Cruz
Biotechnology, Dallas, TX), rabbit anti-Flag (F7425; Sigma-Alrich), goat
anti-GST (27457701V; GE Healthcare, Issaquah, WA), rabbit anti-GFP
(Ab290; Roche, Basel, Switzerland), mouse anti-a-tubulin (T9026;
Sigma-Aldrich), mouse anti-active-b-catenin (clone 8E7; Millipore,
Billerica, MA), horseradish peroxidase (HRP)-conjugated goat anti-
mouse (170-6516) and goat anti-rabbit (170-6515, both from BioRad,
Hercules, CA), and HRP-conjugated donkey anti-goat (sc-2020; Santa
Cruz Biotechnology). Signal was revealed using the SuperSignal Femto
detection kit (Thermo Scientific, Rockford, IL) and detected using
LAS3000 (GE Healthcare), ChemiDoc (BioRad) or film (Fig. 2F, Agfa).
For immunoprecipitation–pulldown experiments, cells were lysed in IP
Lysis buffer [20 mM Tris-HCl pH 7.4, 150 mM NaCl, 25 mM b-glycerol
phosphate, 0.5% Igepal CA630, 0.5% Triton X-100 (all from Sigma-
Aldrich), and 16 Complete proteasome inhibitors (Roche)]. Following
centrifugation (15,000 g for 10 min at +4 C˚), cleared extracts were
incubated (6 h at +4 C˚ in an orbital shaker) with anti-Myc (9E10), anti-
Flag (M2) G-protein–sepharose (GE Healthcare) or S-protein agarose
(Novagen, Billerica, MA). Each batch of beads with LAP–Plk4 was
tested for the presence of a Mib1-induced upshift and stored as a 25%
slurry (IP Lysis buffer plus 10% glycerol and 100 mM DTT;280 C˚) until
used in binding assays. His pulldowns were performed in denaturing
conditions [50 mM Tris-HCl, pH 7.4, 300 mM NaCl, 0.5% Triton-X-
100, 0.05% SDS, 10 mM Imidazol and 6 M Urea (all from Sigma-
Aldrich)] using Ni-NTA agarose (Qiagen, Hilden, Germany). Complexes
were pelleted, washed, and subsequently analyzed by western blotting.
In vitro translation, recombinant protein purification and
binding assays
Myc–Plk4, Flag–Mib1 and Flag–Cep152 were translated in vitro (TNT
Quick system; Promega, Madison, WI), mixed with modified IP Lysis
buffer (as above; 0.05% Igepal CA630, 100 mM DTT) and subjected to
immunoprecipitation and washing. GST-tagged proteins were purified as
described previously (Cˇaja´nek and Nigg, 2014). Binding of Mib1-
modified LAP–Plk4 with the GST-tagged Cep192 N-terminus
(recombinant, purified from bacteria) or Cep152 N-terminus (translated
in vitro) was performed in pulldown buffer (20 mM Tris-HCl, pH 7.4,
150 mM NaCl, 25 mM b-glycerol phosphate, 0.5% Igepal CA630,
100 mM DTT) for 45 min (+4 C˚; orbital shaker). Where indicated,
densitometry analysis of blots was performed with ImageJ or ImageLab
(Fig. 2D; BioRad).
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Mass spectrometry analyses of ubiquitination
Following 4 h of treatment with proteasome inhibitor MG132 (10 mM),
LAP–Plk4 was isolated from HEK293T cell extracts prepared 18 h after
transfection, using S-protein agarose. Proteins were eluted, reduced,
alkylated, digested with trypsin overnight, and then purified with C-18
Microspin columns (Harvard Apparatus, Holliston, MA). Peptides were
separated by using an Easy-Nano-LC system, and liquid-chromatography–
tandem-MS analysis was performed on a hybrid LTQ-Orbitrap mass
spectrometer (both from Thermo Scientific). Obtained protein spectra were
searched against the human proteome database (UniProt). The detection of
ligated ubiquitin was based on ubiquitin-derived di-glycine mass
increments of ubiquitylated peptides (114.1 Da per modified lysine
residue) (Kirkpatrick et al., 2005).
Statistical analyses
Statistical analyses (Student’s t-test or ANOVA with Tukey’s multiple
comparison test) were performed using Prism 6 (GraphPad Software, La
Jolla, CA). *P,0.05, **P,0.01 and ***P,0.001 were considered
statistically significant differences. Results are presented as mean6s.e.m.
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